Effectiveness of an in‐home respite care program to support informal dementia caregivers: A comparative study

Vandepitte, Sophie; Putman, Koen; Noortgate, Nele Van Den; Verhaeghe, Sofie; Annemans, Lieven

doi:10.1002/gps.5164

Cited by 25 publications

(30 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The modest but clinically significant benefits of CARITAS were similar to extant dementia case management, which aimed to enhance patients’ QOL ( d = 0.05) and caregivers’ QOL ( d = 0.21) and lower caregiving burden ( d = 0.12) [36]. Moreover, these effects were also comparable to other forms of non-pharmacological interventions, such as caregivers’ education to improve patient’s QOL ( d = 0.24) [37], home-based respite care programmes to alleviate caregiver burden ( d = 0.30) [38], PCC training ( d = 0.30) to reduce behavioural concerns such as agitation [37], notwithstanding that this evaluation did not involve a control group.…”

Section: Discussionmentioning

confidence: 96%

Evaluating the Outcomes of a Hospital-to-Community Model of Integrated Care for Dementia

Yap

Nicholas

et al. 2020

Dement Geriatr Cogn Disord

View full text Add to dashboard Cite

Introduction: Living with dementia is challenging for persons with dementia (PWDs) and their families. Although multi-component intervention, underscored by the ethos of person-centred care, has been shown to maintain quality of life (QOL) in PWDs and caregivers, a lack of service integration can hinder effectiveness. Methods: CARITAS, an integrated care initiative provided through a hospital-community care partnership, endeavours to provide person-centred dementia care through ambulatory clinic consults, case management, patient and caregiver engagement, and support. We evaluated CARITAS’ clinical outcomes and cost-effectiveness with a naturalistic cross-sectional within-subject design. We assessed patients’ function, QOL, and behavioural problems post-intervention. We estimated CARITAS’ cost-effectiveness from a patient’s perspective, benchmarking it against other dementia treatments and Singapore’s Gross Domestic Product (GDP) per capita. Results: CARITAS care significantly improved health utility (p < 0.001), reduced caregiver burden (p < 0.001), and improved PWDs’ behavioural problems (p < 0.001) related to “memory” (p < 0.001), “disruption” (p = 0.017), and “depression” (p < 0.001). CARITAS’ benefits (dRMBPC = 0.357, dEQ5D index = 0.328, dZBI = 0.361) were comparable to those of other pharmacological and non-pharmacological interventions for dementia. CARITAS costs SG$133,056.69 per quality-adjusted life years gain, yielding an incremental cost-effectiveness ratio of 1.31 and 1.49 against the cost of donepezil in patients with mild Alzheimer’s disease and Singapore’s GDP per capita in 2019, respectively, falling within the cost-effectiveness threshold of 1.0–3.0. Discussion: CARITAS integrated dementia care is a cost-effective intervention that showed promising outcomes for PWDs and their caregivers.

show abstract

Section: Discussionmentioning

confidence: 96%

Evaluating the Outcomes of a Hospital-to-Community Model of Integrated Care for Dementia

Yap

Nicholas

et al. 2020

Dement Geriatr Cogn Disord

View full text Add to dashboard Cite

show abstract

“…Nonetheless, previous studies aimed at identifying the effectiveness of inhome respite care in Taiwan did not examine the impact on caregiver burden (Chen & Chiou, 2015;Chen & Huang, 2010). Other research showed no considerable effects of inhome respite care on caregiver burden (Vandepitte et al, 2019). In a previous study for in-home respite care users in Taiwan, the researchers found that "accessibility" and "availability" are the two aspects where users reported the lowest satisfaction (Chen & Chiou, 2015).…”

Section: Discussionmentioning

confidence: 99%

“…However, only one quantitative study focusing on in-home respite care was included in that review, and it showed that vulnerable caregivers in the intervention group have low plasma epinephrine values after 2 weeks of respite care (Grant et al, 2003). Vandepitte et al (2019) conducted a comparative study to assess the effectiveness of an in-home respite program for dementia caregivers. This comparative study did not show a significant difference in the total caregiver burden between the intervention and control groups after 6 months; however, the desire of the intervention group to institutionalize the patient is significantly lower than that of the control group (Vandepitte et al, 2019).…”

mentioning

confidence: 99%

The Effects of in-Home Respite Care on the Burden of Caregivers in Taiwan

Liao

Liu

et al. 2022

J Appl Gerontol

View full text Add to dashboard Cite

The utilization rate of respite care in Taiwan is low, and past studies that evaluated the effects of in-home respite care on caregiver burden are few. This two-wave panel study used Taiwan’s long-term care plan 1.0 database and included 2342 care recipient–caregiver dyads who used home services to examine the impact of in-home respite care on caregiver burden. Propensity score matching was used to select 323 in-home respite service users matched with 646 nonusers as control groups (1:2 matching). The mixed effect model was applied to estimate the effects of receiving in-home respite care on caregiver burden. Results showed that compared with those of nonusers, caregiver burden scores of service users decreased significantly after receiving in-home respite care for more than 14 days (adjusted B = −0.14, SE = 0.05). The government should prioritize increasing the number of days of in-home respite care for those in need to reduce the caregiver burden.

show abstract

“…The baseline data from a prospective study titled 'Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with dementia' were used [17,18]. Detailed information on the study aim and methodology can be consulted in the protocol paper by [19].…”

Section: Methodsmentioning

confidence: 99%

Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background: Besides the importance of estimating the global economic impact of care for persons with dementia, there is an emerging need to identify the key factors associated with this cost. The aim of this study was to analyze associations between the cost of care in community-dwelling persons with dementia and caregiver characteristics from both the healthcare third party payer perspective and the societal perspective. Methods: Several characteristics based on the cross-sectional data of 355 dyads of informal caregivers and persons with dementia living in Belgium were identified to include in a log-gamma generalized linear model and were used in a multiple linear regression model with bootstrapping to test robustness. Results: The mean monthly cost of care for a community-dwelling person with dementia was estimated at € 2339 (95% CI € 2133 -€ 2545) per person from a societal perspective and at € 968 (95% CI € 825 -€ 1111) per person from a third party payer viewpoint. Informal care accounted for the majority of the monthly costs from the societal perspective. Community based healthcare resource use represented the largest cost from the third party perspective. According to the regression analyses, a higher level of functional dependency of the person with dementia and a higher educational level of the caregiver were associated with a higher monthly cost from both a third party payer perspective and a societal perspective. In addition, being retired and a higher quality of life in the caregivers were associated with a lower monthly cost of care from the societal perspective.Conclusions: Several characteristics of the caregiver and the person with dementia were associated with the monthly costs of care from a third party payer and a societal perspective. Despite the lack of clear causal relationships, the results of this study can assist policy makers in planning and financing future dementia care. Trial registration: Clinicaltrials.gov NCT02630446, December 15, 2015.

show abstract

Effectiveness of an in‐home respite care program to support informal dementia caregivers: A comparative study

Cited by 25 publications

References 39 publications

Evaluating the Outcomes of a Hospital-to-Community Model of Integrated Care for Dementia

Evaluating the Outcomes of a Hospital-to-Community Model of Integrated Care for Dementia

The Effects of in-Home Respite Care on the Burden of Caregivers in Taiwan

Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study

Contact Info

Product

Resources

About